EPISODE · Jul 22, 2021 · 24 MIN
Why Ro Is Turning To Walmart For Its Next Phase Of Growth
from Predicting The Turn w/ Dave Knox · host Dave Knox
Started in 2017, Ro is a health care technology company building a patient-centric healthcare system. The pandemic gave rise to a remarkable time of growth for the company, marked by the rise of telehealth and multiple acquisitions by the business. Since just this spring, Ro has launched a one of kind in-home vaccination program, raised $500M in funding, acquired two companies (Modern Fertility and diagnostics startup Kit), and premiered its products across 97% of Walmart stores in the US. I sat down with Rob Schutz, Chief Growth Officer and Co- Founder of Ro, to talk about the company’s growth trajectory, the boom of telehealth during COVID, and their new national rollout with Walmart.
What this episode covers
Started in 2017, Ro is a health care technology company building a patient-centric healthcare system. The pandemic gave rise to a remarkable time of growth for the company, marked by the rise of telehealth and multiple acquisitions by the business. Since just this spring, Ro has launched a one of kind in-home vaccination program, raised $500M in funding, acquired two companies (Modern Fertility and diagnostics startup Kit), and premiered its products across 97% of Walmart stores in the US. I sat down with Rob Schutz, Chief Growth Officer and Co- Founder of Ro, to talk about the company’s growth trajectory, the boom of telehealth during COVID, and their new national rollout with Walmart.
NOW PLAYING
Why Ro Is Turning To Walmart For Its Next Phase Of Growth
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m